Search - tctmd.com

Displaying 321 - 340 of 382

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

March 07, 2012

News Daily News

ASCERT: Long-term Survival Appears to Favor CABG Over PCI for Multivessel Disease

L.A. McKeown

March 07, 2012

News Daily News

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

March 06, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Jason Kahn

March 06, 2012

News Daily News

Ensayo DESTINY: los SLF son Superiores a los SMD en lesiones por debajo de la rodilla

Jason Kahn

March 06, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Daily News

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

March 05, 2012

News Daily News

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

L.A. McKeown

March 05, 2012

News Daily News

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

March 05, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Daily News

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Leah Lawrence

January 05, 2012

News Daily News

Surgical Backup for PCI Makes No Difference in Rates of Death, CABG

L.A. McKeown

December 12, 2011

News Daily News

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

November 06, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

L.A. McKeown

October 28, 2011

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

Advertisement

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

ASCERT: Long-term Survival Appears to Favor CABG Over PCI for Multivessel Disease

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Ensayo DESTINY: los SLF son Superiores a los SMD en lesiones por debajo de la rodilla

Statins Reduce Late Restenosis After SES Implantation

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

SCAAR: Second-Generation DES Improve Hard Outcomes

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Surgical Backup for PCI Makes No Difference in Rates of Death, CABG

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

DES Associated with Less Downstream Lesion Development than BMS

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content